Aditxt (ADTX) Return on Capital Employed (2020 - 2026)
Aditxt (ADTX) recorded quarterly Return on Capital Employed of 979.8% in Q1 2026, up 2.97% quarter-over-quarter from 1009.83% in Q4 2025, and down 84689.0% on a YoY basis from N/an in Q1 2025.
Aditxt (ADTX) Return on Capital Employed (2020 - 2026) Analysis & Trends
Aditxt's Return on Capital Employed history runs 7 years deep, the most recent figure standing at 979.8% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 84689.0% year-over-year to 979.8%; the TTM figure through Mar 2026 stood at 979.8% (down 84689.0% YoY), while the FY2025 annual figure was 161.6%, up 2472.0% from the prior year.
- Return on Capital Employed was 979.8% for Q1 2026 at Aditxt, up from 1009.83% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1035.43% in Q2 2023 to a low of 5089.04% in Q4 2023.
- Historically, Return on Capital Employed has averaged 666.54% across 5 years, with a median of 431.96% in 2022.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed sank 486382 bps in 2023, then soared 472167 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 225.21% in 2022, then tumbled by 2160 bps to 5089.04% in 2023, then surged by 93 bps to 367.37% in 2024, then slumped by 175 bps to 1009.83% in 2025, then climbed by 3 bps to 979.8% in 2026.
- The last three Return on Capital Employed figures came in at 979.8% (Q1 2026), 1009.83% (Q4 2025), and 1295.16% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -979.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -979.80% |
| Dec 31, 2025 | -1,009.83% |
| Sep 30, 2025 | -1,295.16% |
| Jun 30, 2025 | -194.41% |
| Mar 31, 2025 | -132.92% |
| Dec 31, 2024 | -367.37% |
| Sep 30, 2024 | -636.67% |
| Jun 30, 2024 | -441.02% |
| Mar 31, 2024 | -167.67% |
| Dec 31, 2023 | -5,089.04% |
| Sep 30, 2023 | 755.29% |
| Jun 30, 2023 | 1,035.43% |
| Mar 31, 2023 | -767.97% |
| Dec 31, 2022 | -225.21% |
| Sep 30, 2022 | -389.86% |
| Jun 30, 2022 | -993.05% |
| Mar 31, 2022 | -431.96% |
| Dec 31, 2021 | -288.85% |
| Sep 30, 2021 | -159.87% |
| Jun 30, 2021 | -164.37% |